Jeffrey Sherman
Net worth: 1 M $ as of 2026-06-29
Net worth: 1 M $ as of 2026-06-29
Currently, Jeffrey W. Sherman occupies the position of Chief Medical Officer & Executive Vice President at Horizon Therapeutics Plc and Chief Medical Officer & EVP-Regulatory Affairs at Horizon Therapeutics USA, Inc. (a subsidiary of Horizon Therapeutics Plc). Jeffrey W. Sherman is also on the board of Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma Plc and Member-Alumni Board at Feinberg School of Medicine. He previously was Member of American Board of Internal Medicine, Chief Medical Officer & Executive Vice President at NeoPharm, Inc., Chief Medical Officer, SVP-Research & Development at IDM Pharma, Inc., Vice President-Clinical Science at Takeda Global Research & Development Center, Inc., Chief Medical Officer & EVP-Regulatory Affairs at Horizon Pharma, Inc., Head-Oncology Global Medical Operations at Pharmacia Corp., Chief Marketing Officer & Executive Vice President for Hyperion Therapeutics, Inc., President & Director at Drug Information Association, Research Associate at Howard Hughes Medical Institute, Inc. and Member of The National Board of Medical Examiners, Inc. Jeffrey W. Sherman received a doctorate from Chicago Medical School and an undergraduate degree from Lake Forest College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-13 | 174,588 ( 0.1% ) | 1 M $ | 2026-06-29 | |
| 2026-05-18 | 5,000 ( 0.01% ) | 15 250 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Director/Board Member | 2023-10-02 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 2026-06-03 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Horizon Therapeutics USA, Inc.
Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Director/Board Member | 2021-10-04 |
| STRONGBRIDGE BIOPHARMA | Director/Board Member | 2021-09-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 22 |
|---|---|
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Lake Forest College
Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
American Board of Internal Medicine
American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
The National Board of Medical Examiners, Inc.
The National Board of Medical Examiners, Inc. Medical/Nursing ServicesHealth Services Provides high-quality examinations for the health professions | Health Services |
Takeda Global Research & Development Center, Inc. | |
Center for Healthcare Innovation | |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
Horizon Therapeutics USA, Inc.
Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | Health Technology |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company advancing disease-modifying antibodies for the treatment of inflammatory disease | Health Technology |
Select your edition
All financial news and data tailored to specific country editions